Steven Sahn
About
In The Last Decade
Steven Sahn
19 papers receiving 604 citations
Peers
Comparison fields: 5 of 44
- Pulmonary and Respiratory Medicine 600
- Critical Care and Intensive Care Medicine 282
- Surgery 164
- Epidemiology 72
- Cardiology and Cardiovascular Medicine 55
Countries citing papers authored by Steven Sahn
This map shows the geographic impact of Steven Sahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Sahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Sahn more than expected).
Fields of papers citing papers by Steven Sahn
This network shows the impact of papers produced by Steven Sahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Sahn. The network helps show where Steven Sahn may publish in the future.
Co-authorship network of co-authors of Steven Sahn
This figure shows the co-authorship network connecting the top 25 collaborators of Steven Sahn. A scholar is included among the top collaborators of Steven Sahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven Sahn. Steven Sahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | Effect of design modifications on trial outcomes in idiopathic pulmonary fibrosis (IPF): Analysis of data from ASCEND and CAPACITY (CAP) | 1 |
| 3 | 10 | |
| 4 | 0 | |
| 5 | 1 | |
| 6 | 6-minute walk test (6MWT) in patients with idiopathic pulmonary fibrosis (IPF): Confirmation of the minimal clinically important difference (MCID) | 1 |
| 7 | The long-term safety of pirfenidone (PFD) in patients with idiopathic pulmonary fibrosis (IPF) | 1 |
| 8 | Analysis of lung function and survival in RECAP: An open-label extension study of pirfenidone (PFD) in patients with idiopathic pulmonary fibrosis (IPF) | 3 |
| 9 | 16 | |
| 10 | 1 | |
| 11 | 5 | |
| 12 | 425 | |
| 13 | 2 | |
| 14 | 24 | |
| 15 | 17 | |
| 16 | 23 | |
| 17 | 26 | |
| 18 | 6 | |
| 19 | 16 | |
| 20 | 55 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.